Zivo Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Zivo Bioscience Warrants
ZIVOW Stock  USD 0.05  0.00  0.00%   
Zivo Bioscience's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Zivo Bioscience's valuation are provided below:
Gross Profit
66.2 K
Market Capitalization
35.3 M
Revenue
209 K
Quarterly Revenue Growth
1.083
Revenue Per Share
0.056
There are over one hundred nineteen available fundamental gauges for Zivo Bioscience Warrants, which can be analyzed over time and compared to other ratios. All traders should should confirm Zivo Bioscience's prevalent fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable. Market Cap is likely to drop to about 1.5 M in 2026. Enterprise Value is likely to drop to about 1.8 M in 2026

Zivo Bioscience Total Revenue

148,573

Check Zivo Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zivo Bioscience's main balance sheet or income statement drivers, such as Interest Expense of 25.1 K, Other Operating Expenses of 16.3 M or Total Operating Expenses of 16.2 M, as well as many indicators such as Price To Sales Ratio of 563, Dividend Yield of 0.0 or Days Sales Outstanding of 5.61. Zivo financial statements analysis is a perfect complement when working with Zivo Bioscience Valuation or Volatility modules.
  
Build AI portfolio with Zivo Stock
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Zivo Bioscience Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Current Liabilities2.2 M2.3 M5.9 M
Very volatile
Accounts Payable725.7 K853.1 K801.1 K
Pretty Stable
Common Stock Shares Outstanding4.1 M3.9 M1.2 M
Slightly volatile
Other Stockholder Equity164.8 M156.9 M75.5 M
Slightly volatile
Total Liabilities2.4 M2.5 M7.5 M
Pretty Stable
Common Stock4 K4.2 K86.9 K
Slightly volatile
Total Assets1.2 M1.9 M1.5 M
Slightly volatile
Other Current Liabilities1.9 M1.3 M2.2 M
Pretty Stable
Cash1.9 M1.8 M1.1 M
Slightly volatile
Cash And Short Term Investments1.9 M1.8 M1.1 M
Slightly volatile
Liabilities And Stockholders Equity1.2 M1.9 M1.5 M
Slightly volatile
Inventory5.3 K5.6 K5 K
Pretty Stable
Other Current Assets109.6 K104.4 K53.4 K
Slightly volatile
Total Current Assets2 M1.9 M1.2 M
Slightly volatile
Short and Long Term Debt Total277.9 K292.5 K4.4 M
Pretty Stable
Short Term Debt150.9 K158.9 K2.8 M
Very volatile
Intangible Assets1.7 M1.6 M1.2 M
Slightly volatile
Long Term Debt99.3 K104.6 K7.6 M
Slightly volatile
Common Stock Total Equity311 K475 K268 K
Slightly volatile
Short and Long Term Debt118.1 K124.3 K2.6 M
Pretty Stable
Capital Surpluse82.3 M100.4 M70.9 M
Slightly volatile
Capital Stock3.1 K3.3 K144.8 K
Slightly volatile
Long Term Debt Total97.4 K109.5 K119.6 K
Slightly volatile

Zivo Bioscience Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense25.1 K26.4 K1.3 M
Pretty Stable
Other Operating Expenses16.3 M15.5 M6.9 M
Slightly volatile
Total Operating Expenses16.2 M15.4 M6.9 M
Slightly volatile
Research Development3.8 M3.6 M2 M
Slightly volatile
Selling General Administrative12.4 M11.8 M5 M
Slightly volatile
Selling And Marketing Expenses120.3 K178.8 K179.7 K
Pretty Stable
Non Recurring2.5 M3.3 M2.3 M
Slightly volatile

Zivo Bioscience Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow1.9 M1.8 M1.1 M
Slightly volatile
Begin Period Cash Flow299.8 K315.5 K828.7 K
Slightly volatile
Stock Based Compensation11.4 M10.9 M2.9 M
Slightly volatile
Cash Flows Other Operating2.2 M2.1 M795 K
Slightly volatile
Change To Netincome4.6 M4.4 M2.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio563536207
Very volatile
Days Sales Outstanding5.615.945.7883
Slightly volatile
Average Payables582.9 K515.3 K811.8 K
Very volatile
Stock Based Compensation To Revenue56.9454.2352.3478
Very volatile
Capex To Depreciation12.1911.6110.5143
Slightly volatile
EV To Sales553527344
Pretty Stable
Inventory Turnover5.365.654.7056
Slightly volatile
Days Of Inventory On Hand81.2385.51153
Slightly volatile
Payables Turnover0.310.170.0629
Slightly volatile
Sales General And Administrative To Revenue62.0258.82178
Very volatile
Average Inventory6.3 K6.6 K7 K
Pretty Stable
Research And Ddevelopement To Revenue20.8317.95114
Slightly volatile
Capex To Revenue0.04960.05220.0538
Slightly volatile
Cash Per Share0.730.411.0221
Pretty Stable
Days Payables Outstanding3.5 K2.3 K19.6 K
Pretty Stable
Intangibles To Total Assets0.60.580.539
Slightly volatile
Current Ratio0.760.720.4155
Slightly volatile
Receivables Turnover67.264.017.7393
Slightly volatile
Capex Per Share1.341.281.1606
Slightly volatile
Average Receivables1.6 K1.7 K15.7 K
Slightly volatile
Revenue Per Share0.05040.0530.0301
Very volatile
Debt To Assets0.130.1414.4592
Slightly volatile
Operating Cycle5.615.9127
Slightly volatile
Days Of Payables Outstanding3.5 K2.3 K19.6 K
Pretty Stable
Quick Ratio0.760.720.4063
Slightly volatile
Net Income Per E B T0.820.921.1118
Slightly volatile
Cash Ratio0.710.680.385
Slightly volatile
Days Of Inventory Outstanding81.2385.51153
Slightly volatile
Days Of Sales Outstanding5.615.945.7883
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.831.01.0693
Pretty Stable
Fixed Asset Turnover0.310.320.7289
Slightly volatile
Debt Ratio0.130.1414.4592
Slightly volatile
Price Sales Ratio563536207
Very volatile
Asset Turnover0.10.110.0981
Slightly volatile

Zivo Bioscience Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.5 M1.8 M2 M
Slightly volatile
Enterprise Value1.8 M1.9 M6.1 M
Very volatile

Zivo Fundamental Market Drivers

About Zivo Bioscience Financial Statements

Zivo Bioscience investors use historical fundamental indicators, such as Zivo Bioscience's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Zivo Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-276 K-262.2 K
Total Revenue141.5 K148.6 K
Cost Of Revenue97.4 K79.8 K
Stock Based Compensation To Revenue 54.23  56.94 
Sales General And Administrative To Revenue 58.82  62.02 
Research And Ddevelopement To Revenue 17.95  20.83 
Capex To Revenue 0.05  0.05 
Revenue Per Share 0.05  0.05 
Ebit Per Revenue(97.74)(102.62)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill

Additional Tools for Zivo Stock Analysis

When running Zivo Bioscience's price analysis, check to measure Zivo Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zivo Bioscience is operating at the current time. Most of Zivo Bioscience's value examination focuses on studying past and present price action to predict the probability of Zivo Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zivo Bioscience's price. Additionally, you may evaluate how the addition of Zivo Bioscience to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY